Loading…
Oxygenta Pharmaceutical (BSE 524636)₹50.00+3.20%Pharmaceuticals
At the end of the Jun 2026 quarter, Oxygenta Pharmaceutical's shareholders were: promoters 56.56%, DIIs 0.03%, public 43.41%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 10,192 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 29.76% | 29.76% | 29.76% | 33.71% | 53.31% | 51.15% | 51.15% | 57.98% | 57.98% | 55.96% | 56.56% | 56.56% |
| DIIs | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| Public | 70.21% | 70.21% | 70.21% | 66.26% | 46.66% | 48.82% | 48.82% | 41.99% | 41.99% | 44.01% | 43.41% | 43.41% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 8,969 | 9,048 | 10,098 | 9,966 | 10,150 | 10,103 | 10,026 | 10,090 | 10,175 | 10,211 | 10,201 | 10,192 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Virupaksha Organics Limited | Promoter | 56.45% | 0.00 |
| Sravani Reddy Gantla | Public | 6.79% | 0.00 |
| Subba Reddy Bhimavarapu | Public | 4.13% | 0.00 |
| Sunil V. Chawda | Public | 2.98% | 0.00 |
| Kumuda Katasani | Public | 2.29% | 0.00 |
| Manoj S. Chawda | Public | 1.55% | 0.00 |
| Aakanksha M Chawda | Public | 1.53% | 0.00 |
| Snigdha Vankineni | Public | 1.48% | 0.00 |
| Devarapally Venkateswara Reddy | Public | 1.32% | 0.00 |
| Satyanarayana Reddy Bandi | Public | 1.28% | 0.00 |
| B Subba Reddy | Public | 1.25% | 0.00 |
| Chandra Mouliswar Reddy Gangavaram | Promoter | 0.03% | 0.00 |
Promoters held 56.56% of Oxygenta Pharmaceutical at the end of the Jun 2026 quarter, down 1.42 percentage points from 57.98% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 0.03% (unchanged at 0.03% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Oxygenta Pharmaceutical had 10,192 shareholders at the end of the Jun 2026 quarter, against 10,090 a year earlier.
Sravani Reddy Gantla (Public) held 6.79% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.